InBody Co., Ltd. announces an Equity Buyback for 130,000 shares.
February 28, 2017 at 02:18 am
Share
InBody Co., Ltd. (KOSDAQ:A041830) announces a share repurchase program. Under the program, the company will repurchase up to 130,000 shares, for a total expected amount of KRW 3,003 million. The company will repurchase its shares in the open market. The purpose of the share repurchase program is to stabilize the share price and to enhance shareholder value. The maximum number of shares that the company may repurchase on any day is 41,204 shares. The share repurchase program is valid until May 31, 2017. As of February 26, 2017, the company had 71,142 shares in treasury within scope available for dividend and had no shares in treasury through other repurchase.
InBody Co., Ltd., formerly Biospace Co., Ltd., is a Korea-based company engaged in the manufacture of electronic medical devices. The Company mainly produces body composition analyzers under the brand names of InBody and LookinâBody. The Company mainly produces body composition analyzers under the brand name InBody and LookinâBody. Its InBody series products include InBody720, InBody520, InBody230, InBody R20, InBody S20, InBody S10 and InBody J10. Its Lookin' series products include LookinâBody3.0 and LookinâBody Basic, which are used for measuring proteins, minerals, fats, moistures and others. It also provides body mass index (BMI) measuring devices under the brand name of BSM. The Company distributes its products within domestic market and to overseas markets.
INBODY CO.,LTD 
